- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02583802
The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients
The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients by Ear Pills Combined With Shengmai Capsule
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
3.1 research object 3.1.1 case: 3.1.1.1 Beijing University of Chinese Medicine Dongzhimen hospital 48 cases 3.1.1.2 54 cases of Oriental Hospital of Beijing University of Chinese Medicine 3.1.1.3 Chinese Academy of traditional Chinese medicine, Wangjing Hospital, 20 cases 3.1.1.4 28 case of Beijing Pinggu Hospital of Traditional Chinese Medicine 3.1.2 diagnostic criteria: 3.1.2.1: syndrome score standard: according to the traditional Chinese medicine clinical research guiding principle (2002), chronic renal failure syndrome of deficiency of both qi and Yin compiled score table and determine the inclusion criteria.
Diagnostic criteria of hypotension in 3.1.2.2:
Referring to the Ministry of health of the people's Republic of China promulgated the "blood purification standard operating procedures (2010 Edition)" in the "blood dialysis hypotension prevention and control standards for the prevention and control of standard operating procedures", the diagnostic criteria are as follows: (1) can be diagnosed: (1) systolic blood pressure reduction of more than 20mmHg; (2) the average arterial pressure decreased more than 10mmHg.
3.1.2.3 mouth thirst intensity score The investigators will mouth thirst intensity score table (XQ) eight problems in the translation into Chinese questionnaire, each question by visual rating scale method and by the patients according to their own scoring. The higher score indicated the mouth thirst more serious or mouth thirst caused discomfort heavier, and the summation of the scores of each question and convert it to a range of 0 to 100 score, resulting score higher mouth thirst more serious degree.
3.1.4.2 on the treatment of Chinese and Western medicine treatment of poor compliance.
3.1.4.3 infection, fever, acute heart failure or diabetes and blood glucose control is not ideal.
3.1.4.4 for the preparation of the capsule and the skin allergic patients with adhesive tape.
3.1.4.5 patients can not cooperate or not sign the informed consent. 3.1.5 removing and dropping standard 3.1.5.1 all cases that are not included in the criteria for inclusion in the inclusion criteria shall be excluded; 3.1.5.2 clinical information is not the whole case to be removed. 3.2 case grouping method This research is to set up experimental group (Western medicine routine + acupoint therapy combined with birth control group) and the control group (Western medicine group). To meet the inclusion exclusion criteria of the subjects, using random number table method to produce random sequence number, according to the random sequence number to the subjects were assigned to different treatment groups.
3.3 treatment method and treatment The clinical design of this study was a randomized crossover trial. This experiment research is divided into two stages, each stage is 8 weeks. Experimental group on regular hemodialysis based on given auricular therapy selected export sympathetic endocrine, God door, massage time for about 1 minute, 3 ~ 5 times / day, each taking one side ear, 3 ~ 7 days take on the other side of the ear; Shengmai capsules and Shengmai Capsules (ChiaTai Qingchunbao Pharmaceutical Co., Ltd., Chinese medicine quasi word Z33021036, every grain of 0.3g. Ingredients: ginseng, ophiopogon root, Schisandra 3 capsules / time, 3 times / day. Control group received regular hemodialysis treatment, completed in the treatment of the first stage. After 4 weeks after a washout period, two groups of cross accept the next phase of treatment.
3.5 observation index 3.5.1 safety index: Into the group, crossover trial and the end of the experiment were used to detect the blood routine hemodialysis patients, before and after dialysis and renal ion, and serum albumin.
3.5.2 evaluation index:
- and KT/V: and URR were measured in the clinical observation of the biochemical, dialysis, and body weight at the end of the biochemical, dialysis, and weight gain of hemodialysis and Improvement Center. URR = (BUN) /BUN (BUN = 100%) + (4 *) + (3.5 * R) * KT/V (R = R) (BUN = 0.03) (LN = UF/W) (BUN =).
- thirst improvement: combined with clinical experience, thirst was divided into eight levels (combined with patients' self perception and thirst intensity score), making a thirst scale, in the group, when the end of the experiment and the end of the experiment, respectively, to observe the improvement of thirst before and after treatment.
- on the basis of the analysis of the improvement of the low blood pressure (first): according to the diagnostic criteria of hypotension in hemodialysis patients, the incidence of hypotension in the experimental group and the second stage was compared with that of the experimental group and the control group.
- the quality of life improvement in dialysis patients: in the clinical observation, the patients were treated with in-depth interviews, the use of key data extraction methods, to reflect the quality of life of patients with dialysis information; in the clinical observation of the patients, the cross exchange and the end of the life quality of SF-36 patients.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Contact
- Name: Beijing University of Chinese Medicine Beijing University of Chinese Medicine
- Email: csdoctor1988@163.com
Study Contact Backup
- Name: Beijing University of Chinese Medicine Beijing University of Chinese Medicine
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100029
- Recruiting
- Beijing University of Chinese Medicine
-
Contact:
- Beijing University of Chinese Medicine
- Email: csdoctor1988@163.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- in the blood purification center hemodialysis (2-4 times / week, the same below) more than 3 months;
- in line with the deficiency of both qi and Yin syndrome score greater than or equal to 9 points and thirsty XQ scores greater than or equal to 8 points; or deficiency of both qi and Yin syndrome score greater than or equal to 9 points and dialysis hypotension occurred frequency is greater than or equal to 1 / 5 of dialysis patients;
- between 18-80, the condition is basically stable;
- have better treatment compliance, signed informed consent.
Exclusion Criteria:
- patients in the blood purification center of the law for less than 3 months.
- the treatment of Chinese and Western medicine treatment of poor compliance.
- infection, fever, acute heart failure or diabetes and blood glucose control is not ideal.
- the patients with the capsule preparation and adhesive tape skin allergy.
- patients unable to cooperate or not sign the informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Control group received regular hemodialysis treatment, no given Ear pills and Shengmai capsule completed in the treatment of the first stage.
After 4 weeks after a washout period, two groups of cross accept the next phase of treatment.
|
|
Experimental: Ear pills and Shengmai capsule
On regular hemodialysis based on given auricular Ear pills and Shengmai capsule
|
The clinical design of this study was a randomized crossover trial.
This experiment research is divided into two stages, each stage is 8 weeks.
After 4 weeks after a washout period, two groups of cross accept the next phase of treatment.
The clinical design of this study was a randomized crossover trial.
This experiment research is divided into two stages, each stage is 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The measurement of blood pressure
Time Frame: 8 weeks
|
According to the diagnostic criteria of hypotension in hemodialysis patients, To summarize the incidence of hypotension in the experimental group and the control group.
|
8 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Beijing University of Chinese Medicine Beijing University of Chinese Medicine, Chinese Ministry of Education
Publications and helpful links
General Publications
- Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):695-704. doi: 10.1016/s0360-3016(01)01512-7.
- Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):725-31. doi: 10.1016/j.ijrobp.2005.02.045.
- Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):61-70. doi: 10.1016/s0360-3016(03)00361-4.
- Pacholke HD, Amdur RJ, Morris CG, Li JG, Dempsey JF, Hinerman RW, Mendenhall WM. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005 Aug;28(4):351-8. doi: 10.1097/01.coc.0000158826.88179.75.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013-ZYLC-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intradialytic Hypotension
-
Chang Gung Memorial HospitalNot yet recruiting
-
China Medical University, TaiwanChang Gung Memorial Hospital; Taipei Veterans General Hospital, TaiwanCompletedIntradialytic Hypotension
-
Western Galilee Hospital-NahariyaCompleted
-
Chang Gung Memorial HospitalUnknownIntradialytic HypotensionTaiwan
-
Chelsea TherapeuticsCompletedIntradialytic HypotensionUnited States
-
Assaf-Harofeh Medical CenterCompletedIntradialytic Hypotension | ImmersionIsrael
-
Centre Hospitalier de BethuneCHU de LilleRecruiting
-
Ain Shams UniversityActive, not recruitingIntradialytic HypotensionEgypt
-
NimedicalUnknownIntradialytic Hypotension
-
Global Monitors, Inc.University of VirginiaCompleted
Clinical Trials on Ear pills
-
Singapore Institute of TechnologyAMILI Pte. Ltd.Active, not recruitingGastrointestinal Microbiome | Protein DigestionSingapore
-
Beijing Tiantan HospitalTasly Pharmaceutical Group Co., LtdActive, not recruiting
-
China National Center for Cardiovascular DiseasesFuwai Yunnan Cardiovascular HospitalRecruitingCoronary Heart Disease | Medicine, Chinese TraditionalChina
-
University of Maryland, BaltimoreNot yet recruitingChronic Pain | Headache
-
Virginia Commonwealth UniversityCompleted
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
Hospital Authority, Hong KongUnknownCerumen Impaction of Both EarsHong Kong
-
Dalian UniversityUnknown
-
National Yang Ming UniversityCompleted